Literature DB >> 9914572

Paget's disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget's disease, and recurrence after surgical excision.

J Fanning1, H C Lambert, T M Hale, P C Morris, C Schuerch.   

Abstract

OBJECTIVE: Our aim was to determine the prevalence of associated vulvar adenocarcinoma, invasive Paget's disease, and recurrence of Paget's disease of the vulva. STUDY
DESIGN: A retrospective review of tumor and pathology registries at 8 institutions is presented. Patients with recurrent disease were excluded. Histologic slide review was performed.
RESULTS: The median age of the 100 patients was 70 years. The median duration of pruritus before surgery was 2 years. Thirty-four percent of patients experienced a recurrence at a median of 3 years. There was a 12% prevalence of invasive vulvar Paget's disease and a 4% prevalence of associated vulvar adenocarcinoma. One patient died of Paget's disease with associated vulvar adenocarcinoma.
CONCLUSIONS: Paget's disease of the vulva is rarely associated with an underlying vulvar adenocarcinoma or invasive Paget's disease, but there is a high recurrence rate.

Entities:  

Mesh:

Year:  1999        PMID: 9914572     DOI: 10.1016/s0002-9378(99)70143-2

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  33 in total

Review 1.  Mammary and extramammary Paget's disease.

Authors:  J Lloyd; A M Flanagan
Journal:  J Clin Pathol       Date:  2000-10       Impact factor: 3.411

2.  [Extensive, painful erosion of the vulva. Extramammary Paget disease].

Authors:  A Sommer; C Appelhans; M Stücker; P Altmeyer; A Kreuter
Journal:  Hautarzt       Date:  2006-04       Impact factor: 0.751

Review 3.  Extramammary Paget's disease of the perineum: Avoiding pitfalls in diagnosis and management.

Authors:  Rajiv Y Chandawarkar; Daniel Ricchuiti; Ibrahim Amjad; Robert E Marsico; Mark D Wells
Journal:  Can J Plast Surg       Date:  2003

4.  Diagnosis, Therapy and Follow-up Care of Vulvar Cancer and its Precursors. Guideline of the DGGG and DKG (S2k-Level, AWMF Registry Number 015/059, November 2015.

Authors:  H G Schnürch; S Ackermann; C D Alt; J Barinoff; C Böing; C Dannecker; F Gieseking; A Günthert; P Hantschmann; L C Horn; R Kürzl; P Mallmann; S Marnitz; G Mehlhorn; C C Hack; M C Koch; U Torsten; W Weikel; L Wölber; M Hampl
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-10       Impact factor: 2.915

Review 5.  A primer on extramammary Paget's disease for the urologist.

Authors:  Joon Yau Leong; Paul H Chung
Journal:  Transl Androl Urol       Date:  2020-02

6.  Paget's disease of the vulva: a clinicopathologic institutional review.

Authors:  Alberto A Mendivil; Lisa Abaid; Howard D Epstein; Mark A Rettenmaier; John V Brown; John P Micha; Marie A Wabe; Bram H Goldstein
Journal:  Int J Clin Oncol       Date:  2011-10-01       Impact factor: 3.402

7.  Successful human epidermal growth receptor 2-targeted therapy beyond disease progression for extramammary Paget's disease.

Authors:  Satomi Watanabe; Masayuki Takeda; Takayuki Takahama; Tsutomu Iwasa; Junji Tsurutani; Junko Tanizaki; Toshio Shimizu; Kazuko Sakai; Yoshitaka Wada; Noritaka Isogai; Kazuto Nishio; Kazuhiko Nakagawa
Journal:  Invest New Drugs       Date:  2016-02-09       Impact factor: 3.850

Review 8.  [TNM classification of gynecologic malignancies : What remains to be done beyond 2017?]

Authors:  L-C Horn; C E Brambs; S Opitz; J Einenkel; D Mayr
Journal:  Pathologe       Date:  2019-02       Impact factor: 1.011

Review 9.  Vulvar carcinoma.

Authors:  R L Coleman; J T Santoso
Journal:  Curr Treat Options Oncol       Date:  2000-06

10.  A pilot study of topical imiquimod therapy for the treatment of recurrent extramammary Paget's disease.

Authors:  Renee A Cowan; Destin R Black; Lien N Hoang; Kay J Park; Robert A Soslow; Floor J Backes; Ginger J Gardner; Nadeem R Abu-Rustum; Mario M Leitao; Eric L Eisenhauer; Dennis S Chi
Journal:  Gynecol Oncol       Date:  2016-05-05       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.